Contact

Representative before the EPO

Company dna kernebeck patentanwalts gmbh
no operation time available
1 office
active in Legal Services

We have observed 19 EP applications Thomas Kernebeck has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12737470

POWDERY MIXTURE FOR PRODUCING TABLETS CONTAINING LEVETIRACETAM

IPC classification:
A61K 9/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12735463

A NEW THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT

IPC classification:
A61K 31/473, A61K 9/107, A61K 9/10, A61K 9/08, A61K 9/00, A61P 25/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12769586

COMPRESSED SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS PARTICULATE VALSARTAN AS THE ACTIVE INGREDIENT

IPC classification:
A61K 31/549, A61K 31/41, A61K 9/20, A61K 9/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14001695

High dose imatinib tablets

IPC classification:
A61K 31/506, A61K 9/28, A61K 9/20
Applicant:
Hetero Research Foundation
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13004915

Compositions of Imatinib

IPC classification:
A61K 31/506, A61K 9/28
Applicant:
Hetero Research Foundation
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13702727

PROCESS FOR PRODUCING A SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE ACTIVE INGREDIENT RASAGILINE

IPC classification:
A61K 31/135, A61K 9/20, A61P 25/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13755280

RITONAVIR COMPOSITIONS

IPC classification:
A61K 31/426
Applicant:
Hetero Research Foundation
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13737527

PHARMACEUTICAL PEMETREXED SOLUTION

IPC classification:
A61K 47/20, A61K 47/18, A61K 31/519, A61K 9/00
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14002689

Composition containing Apomorphine and a Divalent Metal Cation

IPC classification:
A61P 25/16, A61K 31/473, A61K 47/02, A61K 9/08
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14724300

DRUG ADMINISTERING DEVICE AND ASSEMBLY METHOD THEREFORE

IPC classification:
A61M 5/24
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15002887

ORAL FEBUXOSTAT TABLET

IPC classification:
A61K 31/426, A61K 9/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
APPLICATION PUBLISHED
EP15766745

COMPOSITION CONTAINING APOMORPHINE AND A DIVALENT METAL CATION

IPC classification:
A61P 25/16, A61K 31/473, A61K 47/02, A61K 9/08
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
Request for examination was made
EP16000150

METHOD FOR PRODUCING AN APIXABAN GRANULATE

IPC classification:
A61K 9/20, A61K 31/4545, A61K 9/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
The application has been published
EP17189044

TREATMENT OF FRUCTOSE MALABSORPTION

IPC classification:
A61P 1/14, A61K 38/52
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
Request for examination was made
EP16180093

ATORVASTATIN COMPOSITION

IPC classification:
A61K 31/00, A61K 9/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
The application has been published
EP16744351

READY-TO-USE BORTEZOMIB SOLUTION

IPC classification:
A61K 31/69, A61K 9/08
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
Request for examination was made
EP16742280

METHOD FOR PRODUCING A BORTEZOMIB ESTER SOLUTION

IPC classification:
A61K 31/69, A61K 9/08
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
Request for examination was made
EP16203722

SOLID PHARMACEUTICAL ORAL DOSAGE FORM COMPRISING AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT COMPRISING MIRABEGRON

IPC classification:
A61K 31/00, A61K 9/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
The application has been published
EP16778026

ORAL FEBUXOSTAT TABLET

IPC classification:
A61K 31/426, A61K 9/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature